OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitors as Potential Anticancer Agents
Debasish Basak, David Gamez, Subrata Deb
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1867-1867
Open Access | Times Cited: 36
Debasish Basak, David Gamez, Subrata Deb
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1867-1867
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Camilla Anastasio, Isabella Donisi, Vitale Del Vecchio, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations
Prasanna Mohite, Deepak K. Lokwani, Nikhil S. Sakle
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6107-6119
Closed Access | Times Cited: 6
Prasanna Mohite, Deepak K. Lokwani, Nikhil S. Sakle
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6107-6119
Closed Access | Times Cited: 6
Antidiabetic Drugs in Breast Cancer Patients
Wojciech Garczorz, Agnieszka Kosowska, Tomasz Francuz
Cancers (2024) Vol. 16, Iss. 2, pp. 299-299
Open Access | Times Cited: 5
Wojciech Garczorz, Agnieszka Kosowska, Tomasz Francuz
Cancers (2024) Vol. 16, Iss. 2, pp. 299-299
Open Access | Times Cited: 5
New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: a nationwide population-based cohort study
Yun Kyung Cho, Sehee Kim, Myeong‐Jin Kim, et al.
Diabetes & Metabolism (2025), pp. 101605-101605
Closed Access
Yun Kyung Cho, Sehee Kim, Myeong‐Jin Kim, et al.
Diabetes & Metabolism (2025), pp. 101605-101605
Closed Access
Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials
Samuel Dinerman, Yan Shu
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Samuel Dinerman, Yan Shu
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Research Progress of SGLT2 Inhibitors in Cancer Treatment
Xiaoyong Miao, Jianing Zhang, Weiyan Huang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 505-514
Open Access
Xiaoyong Miao, Jianing Zhang, Weiyan Huang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 505-514
Open Access
Recent advances in the role of high-salt diet in anti- and pro-cancer progression
Shiwei Tang, Juan Xu, Ping Wan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shiwei Tang, Juan Xu, Ping Wan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma
Erman Akkuş, Emre Yekedüz, Yüksel Ürün
Clinical Genitourinary Cancer (2025) Vol. 23, Iss. 2, pp. 102314-102314
Closed Access
Erman Akkuş, Emre Yekedüz, Yüksel Ürün
Clinical Genitourinary Cancer (2025) Vol. 23, Iss. 2, pp. 102314-102314
Closed Access
Doxorubicin-induced cardiometabolic disturbances: what can we do?
Ashot Avagimyan, Nana Pogosova, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 6
Open Access
Ashot Avagimyan, Nana Pogosova, Manfredi Rizzo, et al.
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 6
Open Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2025) Vol. 10, Iss. 1, pp. 101-109
Open Access
Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents
Azura Murphy, Ritis Kumar Shyanti, Manoj Kumar Mishra
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Azura Murphy, Ritis Kumar Shyanti, Manoj Kumar Mishra
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
SGLT inhibitors for improving Healthspan and lifespan
James H. O’Keefe, Robert Weidling, Evan L. O’Keefe, et al.
Progress in Cardiovascular Diseases (2023) Vol. 81, pp. 2-9
Open Access | Times Cited: 14
James H. O’Keefe, Robert Weidling, Evan L. O’Keefe, et al.
Progress in Cardiovascular Diseases (2023) Vol. 81, pp. 2-9
Open Access | Times Cited: 14
Cancer and Cardiovascular Disease: The Conjoined Twins
Mohammad Zmaili, Jafar Alzubi, Motasem Alkhayyat, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1450-1450
Open Access | Times Cited: 4
Mohammad Zmaili, Jafar Alzubi, Motasem Alkhayyat, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1450-1450
Open Access | Times Cited: 4
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Yogita Dhas, Nupur Biswas, M R Divyalakshmi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 4
Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Effects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 3
Takumi Kawaguchi, Yoshiyuki Fujishima, Daisuke Wakasugi, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 12, pp. 1120-1132
Open Access | Times Cited: 3
Association of SGLT2 Inhibitors with Incident Cancer
Yuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Diabetes & Metabolism (2024) Vol. 50, Iss. 6, pp. 101585-101585
Closed Access | Times Cited: 3
Yuta Suzuki, Hidehiro Kaneko, Akira Okada, et al.
Diabetes & Metabolism (2024) Vol. 50, Iss. 6, pp. 101585-101585
Closed Access | Times Cited: 3
Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study
Tomasz Tabernacki, Lindsey Wang, David C. Kaelber, et al.
(2024)
Open Access | Times Cited: 2
Tomasz Tabernacki, Lindsey Wang, David C. Kaelber, et al.
(2024)
Open Access | Times Cited: 2
SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23)
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
Harold A. Chinyama, Wei Li, Ntlotlang Mokgautsi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16396-16396
Open Access | Times Cited: 7
Harold A. Chinyama, Wei Li, Ntlotlang Mokgautsi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16396-16396
Open Access | Times Cited: 7
Design, synthesis, cell imaging, and bioactivity assessment of novel Rhodamine-Pyrimidine nido-carborane derivatives as fluorescent anticancer agents
Meng Zhou, Tao Jin, Ying Liu, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137211-137211
Closed Access | Times Cited: 7
Meng Zhou, Tao Jin, Ying Liu, et al.
Journal of Molecular Structure (2023) Vol. 1299, pp. 137211-137211
Closed Access | Times Cited: 7
Cardioprotective Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Cancer Treated With Anthracyclines: An Observational Study
Ayman R. Fath, Mostafa Aglan, Amro Aglan, et al.
The American Journal of Cardiology (2024) Vol. 222, pp. 175-182
Closed Access | Times Cited: 2
Ayman R. Fath, Mostafa Aglan, Amro Aglan, et al.
The American Journal of Cardiology (2024) Vol. 222, pp. 175-182
Closed Access | Times Cited: 2
Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study
Tomasz Tabernacki, Lindsey Wang, David C. Kaelber, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2377-2377
Open Access | Times Cited: 1
Tomasz Tabernacki, Lindsey Wang, David C. Kaelber, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2377-2377
Open Access | Times Cited: 1
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?
Carlos A Gongora, Lili Zhang, Juan Lopez Mattei, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Carlos A Gongora, Lili Zhang, Juan Lopez Mattei, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
